PMID: 8957368Dec 1, 1996Paper

Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion

The Annals of Thoracic Surgery
A P YimJ K Ho

Abstract

Talc has been generally accepted to be the most effective sclerosant for chemical pleurodesis, although the optimal route of administration remains unclear. We designed a prospective, randomized study to compare video-assisted thoracoscopic talc insufflation with bedside talc slurry in the treatment of malignant pleural effusion. From September 1993 to November 1995, 57 patients were recruited and randomized to either video-assisted thoracoscopic talc insufflation under general anesthesia (n = 28) or talc slurry by the bedside (n = 29). Patients with poor general condition (Karnofsky score less than 30%), poor pulmonary function (forced expiratory volume in 1 second less than 0.5 L), or trapped lungs were excluded from this study. Five grams of purified talc was used for either video-assisted thoracoscopic talc insufflation or talc slurry. There was no statistically significant difference between the two groups of patients with respect to age, sex ratio, chest drainage duration, postprocedural hospital stay, parenteral narcotics requirement, complications, or procedure failure (ie, recurrence). Video-assisted thoracoscopic talc insufflation has not been shown to be a superior approach compared with talc slurry in our study. Bec...Continue Reading

References

Jul 1, 1976·The Annals of Thoracic Surgery·R H Adler, I Sayek
Mar 11, 1975·Cancer·N MartiniE J Beattie
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E BallatoriA Del Favero
Oct 1, 1963·British Journal of Diseases of the Chest·A SENGUPTA

❮ Previous
Next ❯

Citations

Nov 25, 1997·Journal of Surgical Oncology·Y IchinoseY Terazaki
Nov 18, 2000·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·M HigashiyamaT Horai
Sep 29, 1999·Cardiovascular and Interventional Radiology·A I BloomJ M LaBerge
Jul 22, 2005·Surgery Today·Dalokay KilicCem Kadilar
Jun 12, 2002·Current Treatment Options in Oncology·L B Reeder
Jun 15, 2010·Advances in Therapy·Mateen H UzbeckMarcus P Kennedy
Nov 23, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Alessandro StefaniUliano Morandi
May 29, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Valiant UkaleOlle Widström
May 13, 1999·The Annals of Thoracic Surgery·R E MitchemG R Reisz
Mar 14, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hans-Jurgen MagerFranz Schramel
May 26, 1999·Respirology : Official Journal of the Asian Pacific Society of Respirology·A P YimS Wan
Jul 17, 1999·Current Opinion in Pulmonary Medicine·J J Erasmus, E F Patz
Jul 17, 1999·Current Opinion in Pulmonary Medicine·A P Yim
Jun 11, 2002·Current Opinion in Pulmonary Medicine·Jeffrey S Pollak
Jun 29, 2004·Current Opinion in Pulmonary Medicine·Sophie D WestY C Gary Lee
Oct 11, 2008·American Journal of Clinical Oncology·George BalassoulisDimitrios Patakas
May 31, 2007·Current Opinion in Pulmonary Medicine·David Ryan Stather, Alain Tremblay
Apr 24, 2009·Current Opinion in Pulmonary Medicine·Roberto F CasalCarlos A Jimenez
May 4, 2011·Current Opinion in Pulmonary Medicine·Helen E DaviesY C Gary Lee
May 16, 2013·Current Opinion in Pulmonary Medicine·Helen E Davies, Y C Gary Lee
May 7, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Paul MacEachern, Alain Tremblay
May 25, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ritesh AgarwalSurinder K Jindal
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society
Dec 9, 2000·American Journal of Respiratory and Critical Care Medicine·S A Sahn
Jun 21, 2008·American Journal of Respiratory and Critical Care Medicine·Y C Gary Lee, Sylwia Wilkosz
Jul 28, 2007·Annals of Surgical Oncology·Jared L Antevil, Joe B Putnam
Oct 7, 2011·Indian Journal of Palliative Care·Dk MudulyNk Shukla
Sep 23, 2014·Current Treatment Options in Oncology·Andrew J Sweatt, Arthur Sung
May 3, 2003·Thorax·G AntunesUNKNOWN Pleural Diseases Group, Standards of Care Committee, British Thoracic Society
Oct 12, 2010·Chest·Chakravarthy ReddyDavid Feller-Kopman
Oct 6, 2007·Chest·Paul A KvaleUNKNOWN American College of Chest Physicians
Apr 11, 2015·Wiener klinische Wochenschrift·Marta KorsicZoran Janevski
Jul 23, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T SiorisA Knuuttila
Oct 2, 2007·Surgical Oncology·Warren J GasperPierre R Theodore
Jun 21, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rajesh ThomasY C Gary Lee
Jun 9, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Y C Gary Lee, Richard W Light
Nov 28, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Helen E DaviesY C Gary Lee
May 28, 2004·Expert Opinion on Pharmacotherapy·Mark Weatherhead, George Antunes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.